Found: 5
Select item for more details and to access through your institution.
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 2, p. 157, doi. 10.1111/j.1463-1326.2008.00994.x
- By:
- Publication type:
- Article
Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response.
- Published in:
- Diabetes, Obesity & Metabolism, 2005, v. 7, n. 6, p. 692, doi. 10.1111/j.1463-1326.2005.00539.x
- By:
- Publication type:
- Article
The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: a randomized double-blind placebo-controlled trial.
- Published in:
- Ultrasound in Obstetrics & Gynecology, 1998, v. 12, n. 5, p. 334, doi. 10.1046/j.1469-0705.1998.12050334.x
- By:
- Publication type:
- Article
Improved Blood Pressure (BP) Lowering in Hypertensive Patients (pts) with Type 2 Diabetes (T2DM) with Vildagliptin Compared with Pioglitazone.
- Published in:
- Diabetes, 2007, v. 56, p. A548
- By:
- Publication type:
- Article
Vildagliptin Significantly Decreases Blood Pressure (BP) in Hypertensive Patients (pts) with Type 2 Diabetes (T2DM) Compared with Metformin.
- Published in:
- Diabetes, 2007, v. 56, p. A139
- By:
- Publication type:
- Article